IIM was first described in monocytes from BCG-vaccinated patients, which showed increased expression of proinflammatory cytokines such as TNF-α, IL-6 and IFN-γ as well as increased clearance capacity in response to secondary infection with Mycobacterium tuberculosis or Candida albicans (48, 55). Here, IL6 is linked to infection.